Sign in

CIK 0001607678 · Large accelerated filer

Viking Therapeutics, Inc.

Sign in to watch
Ticker
VKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
461073877
Phone
858-704-4660
Business address
9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-10 Aubuchon Neil William Chief Commercial Officer Purchase +4,475 $33.50 $150K 4,475
2025-03-31 Rouan Sarah Kathryn Director Purchase +1,240 $24.15 $30K 1,240
2025-03-31 Rouan Sarah Kathryn Director Purchase +1,240 $24.15 $30K 1,240
2022-05-02 FOEHR MATTHEW W Director Purchase +45,000 $2.47 $111K 111,250
2021-06-10 FOEHR MATTHEW W Director Purchase +20,000 $5.69 $114K 66,250
2018-05-31 SINGLETON J MATTHEW Director Purchase +9,500 $9.82 $93K 9,500
2018-05-29 Rowland Charles A Jr Director Purchase +30,000 $5.16 $155K 30,000
2018-05-29 Webster Stephen W Director Purchase +8,000 $5.21 $42K 8,000
2018-05-29 MACARTNEY LAWSON Director Purchase +47,965 $5.22 $250K 47,965
2016-11-15 FOEHR MATTHEW W Director Purchase +13,000 $1.21 $16K 39,250
2016-04-13 FOEHR MATTHEW W Director Purchase +20,000 $1.24 $25K 26,250
2015-05-04 FOEHR MATTHEW W Director Purchase +6,250 $8.00 $50K 6,250

Page 1 of 1 · 12 trades